Second Half Full
Longevity Intelligence

Define your Market.
Find the white space.
Build from your differentiated advantage.

Almost 9 in 10 adults are open to what you offer — but they aren't in the market yet. The 5% already here likely aren't the customers that will drive your long-term growth. The Define lever is how you build the position that makes you the right choice for the customers you actually want.

Explore this lever interactively →
180
in-depth consumer interviews
5,000+
direct field interactions
5
sequential positioning steps
IDENTIFY DEFINE BUILD REACH RETAIN DEFINE active
Growth Flywheel
Growth Flywheel Roadmaps
About This Intelligence

Second Half Full intelligence draws from two sources that most research can't combine. Research expertise: decades of consumer adoption research and strategy across industries — applied here to healthspan as the category where those patterns are most complex and most consequential. Operational expertise: first-hand experience building and running Elivate, a nurse-led in-home Healthspan Housecall business (2023–2025), including 180 in-depth consumer interviews and 5,000+ direct field interactions. Most researchers haven't operated. Most operators haven't spent decades studying how categories get adopted. The combination is what makes Second Half Full different.

1 — Industry Intelligence 2 — Second Half Full Intelligence 3 — Sector Variability 4 — Customer Variability 5 — How to Apply It 6 — In Practice
Section 1
Industry Intelligence
Eight category-level questions — and what the research shows is true across the whole market.
How to read this

Category-level answers to the 8 questions that define the Define lever — what's true across the whole market regardless of business type.

Use Section 3 to see how these vary by sector and business type.

Use Section 4 to act on them by customer archetype.

Question
Category finding
Q1
What stage is your business at — and how does that shape the business model you're building?
Most businesses confuse company stage with market stage — and build growth-stage models at a pre-adoption market stage. High-profile failures (Forward Health at $650M, Modern Age at $33M+) shared this pattern: scaling before unit economics or market adoption were proven. The right question is what's the minimum viable version that works at current adoption stage — and what does it need to look like when adoption catches up.
Q2
What type of business are you — and how is it structured to deliver value?
Category value chain position — Upstream (technology, data, biomarker research — beginning of the category value chain), Midstream (treatment products, supplements, devices — middle of the value chain), or Downstream (direct delivery to customers — clinics, mobile services, telehealth) — determines your actual competitive environment. Across 40 firms mapped in the longevity insights space, average Consumer Insights Depth scored 2.73/5, confirming the category is shallow despite apparent crowdedness. Data-rich brands have massive data but no consumer-insights craft. Knowing your category position tells you who your real competitors are and what kind of advantage is achievable.
Q3
What do you genuinely do differently — at the business model, product, or service level?
Business model innovators outperform competitors 2:1 on operating margins vs. product or messaging innovators. Most longevity differentiation is attitudinal-research-based; behavioral segmentation — what consumers actually buy, try, stick with, and abandon — is structurally absent. Business model differentiation is most defensible. Messaging differentiation is easiest to copy and first to be dismissed by the customer.
Q4
What customer needs have you identified that others are missing — and how does your specific advantage address them?
77% of consumers are interested in cellular health; only 20% purchase. The specific unmet needs that create business model opportunity are buried in the gap between what customers say and what they do. 61% said they don't know where to start — but follow-up interviews revealed the actual emotion is embarrassment, not confusion. That distinction is not derivable from a survey.
Q5
How do you design what you do — around your target customers — in a way that creates inherent, defensible difference?
Customer-centric companies grow at 2x the revenue rate of peers — but only 15% consistently incorporate customer insights into decisions. The Jobs-to-be-Done framework produces 86% innovation success vs. 17% industry average. The defensibility doesn't come from the design itself — it comes from the depth of customer insight that generated it, and from the discipline to keep designing from that starting point.
Q6
What does the competitive landscape actually look like at your category value chain position?
400+ dedicated longevity clinics operate in the US and Western Europe with no shared clinical standard — structurally undifferentiated at the treatment level. No dedicated consumer-insights provider serves longevity clinics. Research2Guidance maps five distinct longevity business model archetypes; most businesses couldn't identify which one they are. The category appears crowded from the outside but is shallow in actual competitive differentiation. The highest concentration of current market entrants is in the Downstream position (direct delivery to customers — clinics, mobile services, telehealth), though this reflects where early-stage category activity has been most visible, not necessarily where long-term competitive equilibrium will settle.
Q7
Where is the genuine white space — and how do you know it's real?
White space is validated by two conditions simultaneously: an unmet customer need AND an absence of competitive supply. Biomarker platforms identified the data need correctly but left the adjacent unmet need unmade — customers receiving 27 recommendations with no guidance, no priority order, no one to help them act. The data product was complete. The behavior-change bridge was accidentally omitted. Real white space is usually in the gap between what operators built and what customers actually needed next.
Q8
How defensible is the position you're building — and from what?
The test: would your biggest competitor have to rebuild their operating model from scratch to match it? Structural interdependence — where the parts of your model only work together, not separately — is the mechanism that makes business model advantage hard to replicate. A competitor can copy the format without understanding the customer logic that generated it. They'll get it wrong. The defensibility is in the depth of the work, not in the surface design.
Section 2
Second Half Full Intelligence
These findings come from primary research with people taking action to live healthier longer — across clinic patients, supplement buyers, fitness program members, and retail health shoppers. The cross-category view is the source of the insight — your customers are in here. From 180 in-depth interviews and 5,000+ direct field interactions.
How to read this section
Where Section 1 shows category-level answers, this section shows what Second Half Full's primary research adds — insights from 180 in-depth interviews and 5,000+ direct field interactions that aren't in market data alone.
Q1 — Stage: most operators are building the wrong model for the wrong moment.
The longevity market is growing, but most individual businesses within it are running growth-stage models at a pre-adoption market stage. High-profile failures (Forward Health at $650M, Modern Age at $33M+) shared the pattern: scaling before unit economics were proven or market adoption was ready. Fewer than 40% of seed-funded health startups successfully raise a Series A; median time seed-to-Series A stretched to 616 days in 2025. The winning early-stage strategy — confirmed by 7wire Ventures analysis — is to enter via a specific, recognized use case, prove the model, then expand. Operators who lead with broad platform positioning at early stage consistently struggle with both customer acquisition and investor confidence.
Q2 — Business type: category value chain position determines your real competitive environment.
Across 40 firms mapped in the consumer longevity insights space, the average Consumer Insights Depth scored 2.73 out of 5 — confirming the category is shallow despite apparent crowdedness. The longevity sector has 400+ dedicated clinics in the US and Western Europe with no shared clinical standard. Data-rich brands (Function Health at $2.5B valuation, Oura at $11B, WHOOP) have massive behavioral data but no consumer-insights craft. Downstream (direct delivery to customers — clinics, mobile services, telehealth) operators who identify themselves by treatment menu rather than their category position routinely compete on the wrong dimensions — protocol claims at a position where relationship depth determines outcomes.
Q3 — Differentiation: business model is most defensible. Messaging is least.
IBM research confirmed business model innovators were twice as likely to outperform competitors on operating margins, with +5% growth over five years versus near-zero for product or messaging innovators. 54% of senior managers now prefer new business models over new products as the primary source of future competitive advantage (Economist Intelligence Unit). Of 40 longevity firms mapped, no dedicated consumer-insights provider serves longevity clinics — the most underserved buyer segment in the space. Most longevity differentiation is attitudinal-research-based; behavioral segmentation (what consumers actually buy, try, and abandon) is structurally absent from the category.
Q4 — Customer needs: the unmet need others miss is in the behavior gap, not the category gap.
77% of consumers are interested in cellular health solutions; only 20% purchase annually (Lumina Intelligence). The healthspan-lifespan gap is projected to widen from 9.8 to 16 years by 2035 in the US. But the specific unmet needs that create business model opportunity are narrower: 61% said they didn't know where to start, and follow-up primary research revealed the actual emotion is embarrassment — not confusion. That distinction is not available from standard surveys. The 30-49-year-old consumer driving category momentum has no dedicated research provider. The behavior gap — what consumers say versus what they do — is where the highest-value unmet needs are hiding.
Q5 — Customer-centric design: the defensibility comes from the insight depth, not the design itself.
Customer-centric companies grow at 2x the revenue rate of less customer-focused peers, but only 15% consistently incorporate customer insights into decision-making (McKinsey). Gartner research across 97,000 customers found 96% of those experiencing high-effort interactions report disloyalty — making Customer Effort Score 1.8x more predictive of loyalty than satisfaction scores. The Jobs-to-be-Done framework produces an 86% innovation success rate (versus 17% industry average) when businesses design from customer outcomes backward. A competitor can replicate a customer-centric format without understanding the customer logic that generated it — and they'll get it wrong.
Strategist POV
"In every category I've studied, the businesses that win long-term are rarely the ones with the best product. They're the ones who chose the right ground to compete on — and stuck to it. Most longevity businesses never make that choice explicitly. They drift into a position based on what they built, not what the market actually needs from them. The Define lever is about making that choice on purpose, before the market makes it for you."
Deirdre Davi · Second Half Full · Decades of cross-industry consumer adoption research
Section 3
Where It Varies
Your sector — the competitive landscape differs fundamentally by business type
How the Define lever plays out differently depending on the type of business you operate — the white space, the competitive forces, and what differentiation actually means in your sector.
How to read this section
The same market dynamics play out completely differently depending on whether you're a service business, a product company, or a large brand entering the category. Find your sector and read from there.
Solution Providers
Clinics, in-home operators, telehealth platforms
Category position: Downstream (direct delivery to customers — clinics, mobile services, telehealth). The highest concentration of current market entrants is in downstream delivery — direct-to-consumer services and clinics — based on the competitive landscape of companies actively marketing to healthspan consumers. This reflects where early-stage category activity has been most visible, not necessarily where the long-term competitive equilibrium will settle.

Where differentiation is defensible: Business model structure — cost architecture, delivery model, customer relationship design. Mobile-first, no fixed overhead, no idle capacity is structurally different from the clinic model. That structural difference is nearly impossible for an established clinic to copy without dismantling its existing economics.

Positioning signal: A Solution Provider that can articulate where it sits in the category value chain, what competitors would need to rebuild to match it, and which specific customer need it addresses better than anyone else has done the Define work. Most cannot. That gap is the competitive opportunity.
Products & Brands
DTC supplements, device makers, biomarker platforms
Category position: Midstream (treatment products, supplements, devices — middle of the value chain). The product shelf is crowded with ingredient-focused claims — NAD+ precursors, urolithin A, adaptogens — built from the same attitudinal research base. The position question for Products is about evidence tier and distribution relationship, not just formulation claims.

Where differentiation is defensible: The path from "I take this supplement" to "I understand what this is doing for me" is almost entirely unmade. The brand that builds visible progress and outcome evidence into the product experience — not just the claims — will own the Midstream customer relationship. Data-rich brands have the inputs; no one has built the bridge from data to behavior change.

Positioning signal: Products that define their position at the category value chain level face a different competitive environment than Solution Providers. Knowing that environment changes what differentiation is actually achievable and worth investing in.
Consumer Brands
Large-cap brands entering longevity
Category position: Upstream (technology, data, biomarker research — beginning of the category value chain) or entering via brand extension. Entering brands bring reach advantage and distribution infrastructure — but face a category credibility and consumer trust deficit. The longevity category is built on insider knowledge and authentic expertise.

Where differentiation is defensible: Entering brands that define their position narrowly — a specific customer problem, a specific clinical area, a specific category value chain partnership — outperform those that use brand equity as a substitute for market definition. The Define question for entering brands is: what does this brand specifically need to be true of in this category, and does our existing positioning make that claim credible?

Positioning signal: Most entering brands treat Define as a messaging exercise ("how do we talk about longevity?") rather than a market structure question ("where do we actually compete, and against whom?"). The businesses that win the entry are those that defined their competitive ground before they built the messaging.
In the Define Playbook
Competitive white space analysis and 90-day positioning plan by sector.
Full competitive landscape by category position, white space identification, and a positioning implementation framework for your sector.
Unlock sector plan →
Section 4
Where It Varies
Your customers — how archetypes respond to different market positions
Once you've defined your position, different customer archetypes respond to it differently. Understanding which archetypes your position attracts — and which it doesn't — is how you test whether your definition is right.
How to read this section
These are the 3 validated archetypes most relevant to the Define lever — how each one evaluates market position and what signals tell them you're the right choice.
The delivery gap — the space between what customers expect and what the market is built to give them.
Across all three buyer types, a consistent structural gap exists between the experience customers are seeking and what the current category is designed to deliver. This is not a quality gap — most businesses in the category are delivering competent service or products. It's a design gap: the business was built for what's operationally efficient, not what the customer actually needed next.

For solution providers: the gap is between what customers expect from a clinic visit and what most clinics are designed to deliver at scale.

For products & brands: the gap is between the purchase intent that product research creates and the follow-through that happens post-purchase.

For consumer brands entering longevity: the gap is between the broad health positioning their brand supports and the specific healthspan action their customer hasn't yet taken.

The business that closes its version of the delivery gap — not through marketing, but through how it's actually built — owns the category position competitors can't copy from the outside.
Validated Archetype 1
Symptom-Driven
"Something is wrong. I need this fixed now."
How they evaluate position
Entered through a specific functional failure. Evaluates market position through urgency and specificity — does this business understand my specific problem and address it directly? Generic longevity positioning is invisible to this archetype. Category language ("optimize," "longevity") doesn't register as relevant.
What signals "right choice"
You name their symptom before they explain it. Your position makes it clear you've solved exactly their problem for people like them. Speed and specificity of response are the position signals that convert this archetype — not breadth of service.
Positioning implication: A position built around a specific symptom cluster — perimenopause fatigue, testosterone decline, brain fog protocols — will attract this archetype more reliably than a broad longevity positioning. The narrower the position, the more visible it becomes to the people who need it most urgently.
Validated Archetype 2
Health-Anxious Preventer
"I've seen what's coming. I need a plan before it's too late."
How they evaluate position
Evaluates position through credibility and specificity to their feared condition. They've been researching intensively — a vague longevity position will be filtered out as not serious enough. They're looking for a provider who takes their specific risk seriously and produces a specific plan.
What signals "right choice"
Condition-specific language in your positioning ("Alzheimer's prevention," "cardiovascular risk reduction") signals that you understand what they're trying to get ahead of. Broad wellness positioning fails this archetype — it signals a business that hasn't defined where it actually competes.
Positioning implication: The Health-Anxious Preventer has a longer decision cycle but deep loyalty once trust is established. A position built around prevention of a specific condition family — rather than general longevity — will convert this archetype at a higher rate and with a stronger long-term relationship.
Validated Archetype 3
Proactive Optimizer
"I want data, access, and a plan. I'm not waiting for symptoms."
How they evaluate position
Already deep in a health protocol — activated by biomarker results or specific books (Attia's Outlive is the most cited). Evaluates position through clinical depth and partner posture, not authority framing. Has done more research than most providers they've encountered and will test whether your position is backed by substance.
What signals "right choice"
Positions that show data, name specific metrics (ApoB, VO2 max, NAD+ bioavailability), and treat the customer as a peer rather than a patient. This archetype is self-identifying — they arrive already searching for what you provide. Your position needs to be visible at the specificity level they're searching at.
Positioning implication: Highest LTV in the dataset. Your competition is not longevity skepticism — it's other providers claiming to offer the same clinical depth and data access. A position differentiated by biomarker specificity, clinical depth, and partner posture wins this archetype. Prescriptive authority positioning loses them.
When your position attracts more than one archetype

A well-defined position often attracts primarily one archetype while remaining accessible to others. The test is not whether all three archetypes respond — it's whether your primary target archetype responds strongly and with high conversion. Diffuse positioning that tries to speak to all three typically reaches none of them at the depth that drives conversion. If your current messaging produces mixed archetype signals — some Symptom-Driven customers, some Optimizers — your position may not yet be defined clearly enough to be visible to either group at the depth that drives action.

In the Define Playbook
Full archetype-to-position mapping for all three buyer types.
How each archetype evaluates and selects a market position — with sector-specific differentiation frameworks and competitive white space analysis.
Unlock full profiles →
Section 5
How to Apply It
The category-level moves that work regardless of business type. Each action includes the signal that tells you it’s working.
How to read this section
These actions apply at the category level — they can work for any business targeting customers taking action to live healthier longer. The Growth Playbook takes each one further: built for your specific business type, your customer archetypes, and your growth priorities.
Action 1 — Define your difference
Most businesses have messaging differentiation, not product or model differentiation. Know which one you have and make it your center of gravity.

Before you can define a market position, answer one honest internal question: where does your differentiation actually live? In what you SAY (messaging — copyable in 30 days)? In your PRODUCT? In your PROCESS? In your BUSINESS MODEL (the structural choice that’s hardest to replicate)?

Business model innovators are 2× as likely to outperform competitors on operating margins (IBM CEO Report / MIT Sloan). Most businesses believe they have product or model differentiation when they have messaging differentiation. In a category with 400+ dedicated clinics and no shared clinical standard, most believe they are differentiated. The customer cannot tell the difference.

Apply two tests: (1) “Could anyone else say this?” If a competitor could make the same claim, it is not a differentiation. (2) “Is this just ‘we do X better’?” Comparative claims anchor your identity to a competitor’s category rather than creating your own.

Signal of success: You can name your differentiation layer without pausing — and you believe it would take a competitor at least a year to replicate it. If you hedge on either, the differentiation isn’t as deep as assumed.
Action 2 — Find where that difference is an advantage
Your difference only becomes a position when it matters to a specific customer in a specific competitive context.

A difference becomes an advantage when it meets a real unmet need where no one else is meeting it. Map two things: what your target customer actually needs before they found you, and where in the competitive landscape that need is unoccupied.

The middle market is a documented example of unoccupied space: the $200 supplement and the $25,000 executive physical are both well-served. The $2,500/year accessible expert-guided program with measurable progress has almost no supply. 70%+ of customers in this category will pay premium when quality signals are present and comparables don’t exist.

Map your competitive landscape against two axes: what competitors offer versus what customers in your target archetype actually need. If your analysis only finds messaging white space, the position is copyable in 30 days. Find the intersection where your internal advantage meets a real gap for a real customer.

Signal of success: You can name 2–3 specific things your target customer cannot get elsewhere that you provide — and you believe those things live in your business model or process, not just your messaging.
Action 3 — Validate your positioning is working
Your position comes from within first — but it’s only working when you hear it back from customers and prospects.

Once the internal work is done, validate externally — and prioritize prospects over current customers. Ask: “If you were describing us to someone who might benefit from what we do, what would you say?” The unprompted answer is your brand position.

A satisfied current customer will find kind words. A prospect who self-identifies as your intended buyer before ever interacting with you is the real signal. When prospects describe you accurately in the language you intended, without prompting, your positioning is doing commercial work.

For products and brands: the validation test is whether customers describe your product in terms of what it does for them specifically, or in the generic category language you’re trying to escape.

Signal of success: Prospects describe you accurately in the language you intended, without prompting. If what prospects say back doesn’t match what you intended them to understand, the positioning gap is still open.
Section 6
How one operator applied the Define lever — mobile-first positioning as a structural decision.
Elivate was a nurse-led in-home Healthspan Housecall business operating from 2023–2025. Every lever of the Growth Flywheel was applied from concept to scale. This is how the Define lever played out in practice — one operator's decisions, results, and what it revealed about market position.
The positioning challenge

In-home health service delivery sits at the Downstream position in the category value chain — the last mile, delivering directly to the customer's body and home. The conventional model for that position was the IV clinic: fixed location, nurse on-site, customers book and come in. In-home delivery existed as a premium add-on in that model — a surcharge for convenience, layered on top of the clinic economics. Elivate's Define question was whether that model was the right ground to compete on — or whether it was inherited from a different category and applied to a different set of customer needs.

The decision Elivate made

Elivate chose to build exclusively for mobile-first, in-home delivery — locking in that position not as a premium add-on but as the only model. The entire infrastructure was designed without fixed clinical overhead, so in-home delivery carried no cost premium. The sector choice and the unit economics were the same decision.

This is the Define lever applied at the business model level. IV clinic chains that could have offered in-home delivery didn't — because they needed customers in-store to upsell additional services and amortize fixed overhead. That was supply-side incentive misalignment overriding demonstrated customer demand. Elivate's position — built mobile-first from the beginning, so the fixed overhead that makes in-home delivery expensive never existed — was structurally unreachable by an established clinic without dismantling everything they'd built.

The result
70%
of customers prefer in-home · model built around that signal
$0
Fixed overhead premium — in-home at standard pricing because the clinic model was never adopted
85%
Repeat booking rate — driven by service model design, not treatment protocol
This is one business's application of the Define lever. The framework, findings, and research in this document apply across all three buyer types.

See the full five-lever arc →